2nd Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery

Confirmed Speakers


Confirmed Speakers

PL05 - Affinity Selection Mass Spectrometry (ASMS) for Experimental Target Tractability Assessment (eTA)
Dr Lauren KUSTIGIANDr Lauren KUSTIGIAN
(GSK, Collegeville, PA, United States)

Read more
PL02 - Challenges and Opportunities in the Application of Affinity Selection Mass Spectrometry in Early Drug Discovery
Dr Manuel Francisco MOLINA-MARTINDr Manuel Francisco MOLINA-MARTIN
(LILLY LABORATORIES, Madrid, Spain)

Read more
PL01 - Using Affinity-selection MS to Find Compounds that Disrupt RNA Structure and X-Chromosome Inactivation via Xist
Dr Elliott B. NICKBARGDr Elliott B. NICKBARG
(MERCK RESEARCH LABORATORIES, Boston, United States)

Read more
PL04 - Affinity Selection-Mass Spectrometry for Oligonucleotides, Proteins, Cells, and Animals
Prof. Bradley Lether PENTELUTEProf. Bradley Lether PENTELUTE
(MASSACHUSETTS INSTITUTE OF TECHNOLOGY, Cambridge, MA, United States)

Read more
PL03 - Utilizing Mass Spectrometry to Discover RNA-binding Small Molecules
Dr Scott RUSINDr Scott RUSIN
(ARRAKIS THERAPEUTICS, Waltham, MA, United States)

Read more
PL06 - Difficulties and Solutions Along the ASMS Data Analysis Pathway
Dr Mark SPEARSDr Mark SPEARS
(VIRSCIDIAN, Cary, NC, United States)

Read more

Organised by

Copyright 2022 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys